Lupin appoints Abdelaziz Toumi as CEO of its API CDMO subsidiary
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Subscribe To Our Newsletter & Stay Updated